-
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting StentsYL Han, B Xu, NeoVas Randomized Controlled Trial Investigators -
Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populationsZhang L, Zhang S, Ge J et al.
-
Coronary flow velocity reserve predicts adverse prognosis in women with angina and noobstructive coronary artery disease: resultsfrom the iPOWER studyJ Schroder, MM Michelsen, ND Mygind et al.
-
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary InterventionBrilakis ES, Mashayekhi K, Tsuchikane E et al.
-
Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic StudyD Pellegrini, R Kawakami, G Guagliumi et al.
-
Guidelines in review: Comparison of the 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes and the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationPrejean SP, Din M, Reyes E et al.
-
When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes?Lu TH, Li ST, Yin WH et al.
-
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed TomographyPatel MR, Dehmer GJ, American College of Cardiology Foundation Appropriateness Criteria Task Force et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
